A cost-benefit analysis of the immunisation of children against respiratory syncytial virus (RSV) using the English Hospital Episode Statistics (HES) data set.
about
Anti-RSV prophylaxis efficacy for infants and young children with cystic fibrosis in IrelandCathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.First versus second year respiratory syncytial virus prophylaxis in chronic lung disease (2005-2015).Validation of the Hospital Episode Statistics Outpatient Dataset in England.Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles.
P2860
A cost-benefit analysis of the immunisation of children against respiratory syncytial virus (RSV) using the English Hospital Episode Statistics (HES) data set.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A cost-benefit analysis of the ...... ode Statistics (HES) data set.
@ast
A cost-benefit analysis of the ...... ode Statistics (HES) data set.
@en
type
label
A cost-benefit analysis of the ...... ode Statistics (HES) data set.
@ast
A cost-benefit analysis of the ...... ode Statistics (HES) data set.
@en
prefLabel
A cost-benefit analysis of the ...... ode Statistics (HES) data set.
@ast
A cost-benefit analysis of the ...... ode Statistics (HES) data set.
@en
P2860
P1476
A cost-benefit analysis of the ...... ode Statistics (HES) data set.
@en
P2093
Gareth Thomas
P2860
P2888
P356
10.1007/S10198-014-0662-9
P577
2015-01-04T00:00:00Z